managed dsip ii equity strategy Breckinridge Capital Advisors A surprising deal from Vertex

A surprising deal from Vertex Pharmaceuticals adds to Big Pharma's acquisitive streak as Crinetics folds into the cystic fibrosis drugmaker. Meanwhile, IPOs and venture capital raises trend upward, but mostly for derisked Emerging Private Equity Trends: A Deep Dive into Investment Shifts Private Equity for Insurers: Unlocking Capital Efficiency under Solvency II CVC How to Manage Your Management Equity Plan Why DEI in Private Equity Matters More Than Ever Private Equity Deal Sourcing Guide for 2025

SKU: 31219695340 · From eiffelbuilders.com